Ping-Yen Liu
Quick facts
Marketed products
- Clopidogrel first
- Ticagrelor first · Cardiovascular
Ticagrelor is a direct-acting P2Y12 receptor antagonist that inhibits platelet aggregation by blocking adenosine diphosphate (ADP) signaling.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Ping-Yen Liu
What are Ping-Yen Liu's marketed drugs?
Top marketed products include Clopidogrel first, Ticagrelor first.
Related
- Clopidogrel first
- Ticagrelor first · Cardiovascular
- Sector hub: All tracked pharma companies